<DOC>
	<DOC>NCT02857400</DOC>
	<brief_summary>Prospective, open label, randomized and multicentric study evaluating the efficacy of an organized consultation "return home" compared to a current standard of care in patient hospitalized due to metastatic solid tumor cancer. Subject will be randomized (1:1) as described below : â€¢ Arm A (standard) : current standard of care ; connection documentation faxed to GP ( General practitioner) on the day of patient's discharge Arm B (experimental) : CREDO standard of care, organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP</brief_summary>
	<brief_title>Evaluation of an Organized Consultation "Return Home" of Patients With a Metastatic Cancer (CREDO)</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Second Primary</mesh_term>
	<criteria>1. Age &gt; 18 years old 2. Subject hospitalized in an oncology dedicated center for administration of the first chemotherapy cycle. 3. Subject with metastatic solid tumor whatever the organ 4. subject planned to be discharged home after chemotherapy administration 5. Affiliated to the French social security system. 6. Subjects must provide written informed consent prior to any studyspecific procedure or assessment 1. Subject included in another trial with therapeutic purpose 2. Subject or close circle if applicable unreachable by phone 3. Pregnant or breastfeedings women 4. Any serious and/or unstable preexisting psychiatric,familial, geographic or social condition that could interfere with medical followup and compliance to study procedures 5. Subject law protected</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>